Alnylam Pharmaceuticals Inc (ALNY.O)

ALNY.O on Nasdaq

78.18USD
18 Sep 2014
Price Change (% chg)

$0.49 (+0.63%)
Prev Close
$77.69
Open
$79.22
Day's High
$79.75
Day's Low
$77.59
Volume
918,805
Avg. Vol
690,460
52-wk High
$112.57
52-wk Low
$47.03

ALNY.O

Chart for ALNY.O

About

Alnylam Pharmaceuticals, Inc. (Alnylam) is a biopharmaceutical company developing therapeutics based on ribonucleic acid interface (RNAi). Its Alnylam 5x15, is focused on the development and commercialization of novel RNAi therapeutics for the treatment of genetically defined diseases. Its core programs in clinical or pre-clinic... (more)

Overall

Beta: 1.68
Market Cap (Mil.): $5,932.01
Shares Outstanding (Mil.): 76.35
Dividend: --
Yield (%): --

Financials

  ALNY.O Industry Sector
P/E (TTM): -- 143.76 33.47
EPS (TTM): -5.27 -- --
ROI: -51.43 -2.42 17.39
ROE: -57.11 -7.11 18.25
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks